151 related articles for article (PubMed ID: 21725373)
1. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.
Braamse AM; Gerrits MM; van Meijel B; Visser O; van Oppen P; Boenink AD; Cuijpers P; Huijgens PC; Beekman AT; Dekker J
Bone Marrow Transplant; 2012 Jun; 47(6):757-69. PubMed ID: 21725373
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
Strullu M; Rialland F; Cahu X; Brissot E; Corradini N; Thomas C; Blin N; Rialland X; Méchinaud F; Mohty M
Eur J Haematol; 2012 Jun; 88(6):504-9. PubMed ID: 22372430
[TBL] [Abstract][Full Text] [Related]
4. Self-reported quality of life in long-term survivors of childhood lymphoblastic malignancy treated with hematopoietic stem cell transplantation versus conventional therapy.
Sundberg KK; Wettergren L; Frisk P; Arvidson J
Pediatr Blood Cancer; 2013 Aug; 60(8):1382-7. PubMed ID: 23519958
[TBL] [Abstract][Full Text] [Related]
5. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method.
Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D
Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
[TBL] [Abstract][Full Text] [Related]
7. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
8. Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation.
Park JE; Kim KI; Yoon SS; Hahm BJ; Lee SM; Yoon JH; Shin WG; Lee HS; Oh JM
Pharmacotherapy; 2010 Dec; 30(12):1239-46. PubMed ID: 21114391
[TBL] [Abstract][Full Text] [Related]
9. [Second transplantation for graft failure after allogeneic hematopoietic stem cell transplantation--a retrospective survey by Kanto Study Group for Cell Therapy].
Hagihara M; Kanamori H; Sakai M; Mori T; Nakaseko C; Aotsuka N; Uehara T; Sakura T; Yoshiba F; Kawai N; Tanaka M; Fujisawa S; Ohwada C; Wakita H; Yokota A; Kawamura T; Maruta A; Sakamaki H; Okamoto S;
Rinsho Ketsueki; 2010 Jun; 51(6):390-7. PubMed ID: 20622484
[TBL] [Abstract][Full Text] [Related]
10. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients.
Shapira MY; Resnick IB; Bitan M; Ackerstein A; Samuel S; Elad S; Miron S; Zilberman I; Slavin S; Or R
Bone Marrow Transplant; 2004 Jul; 34(2):155-9. PubMed ID: 15235577
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in adult patients after stem cell transplantation.
Yano K; Kanie T; Okamoto S; Kojima H; Yoshida T; Maruta I; Dohi H; Morishita Y; Ozawa K; Sao H; Sakamaki H; Hiraoka S; Imoto S; Morishima Y; Kodera Y
Int J Hematol; 2000 Apr; 71(3):283-9. PubMed ID: 10846837
[TBL] [Abstract][Full Text] [Related]
12. The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT.
Schulz-Kindermann F; Hennings U; Ramm G; Zander AR; Hasenbring M
Bone Marrow Transplant; 2002 Feb; 29(4):341-51. PubMed ID: 11896432
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factor and quality of life analysis in 160 patients aged > or =60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation.
Deschler B; Binek K; Ihorst G; Marks R; Wäsch R; Bertz H; Finke J
Biol Blood Marrow Transplant; 2010 Jul; 16(7):967-75. PubMed ID: 20144720
[TBL] [Abstract][Full Text] [Related]
14. [Autologous versus allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia].
Wang GR; Xu Y; Zou DH; Zhao YZ; Wang M; Han MZ; Feng SZ; Yan WW; Qiu LG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):544-8. PubMed ID: 16995310
[TBL] [Abstract][Full Text] [Related]
15. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation.
Prieto JM; Atala J; Blanch J; Carreras E; Rovira M; Cirera E; Gastó C
Bone Marrow Transplant; 2005 Feb; 35(3):307-14. PubMed ID: 15580279
[TBL] [Abstract][Full Text] [Related]
16. The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review.
Beattie S; Lebel S
Psychooncology; 2011 Nov; 20(11):1137-50. PubMed ID: 21425389
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.
Hjermstad MJ; Knobel H; Brinch L; Fayers PM; Loge JH; Holte H; Kaasa S
Bone Marrow Transplant; 2004 Aug; 34(3):257-66. PubMed ID: 15170167
[TBL] [Abstract][Full Text] [Related]
18. Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.
Schulz-Kindermann F; Mehnert A; Scherwath A; Schirmer L; Schleimer B; Zander AR; Koch U
Bone Marrow Transplant; 2007 Jun; 39(12):789-99. PubMed ID: 17417661
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Corradini P; Zallio F; Mariotti J; Farina L; Bregni M; Valagussa P; Ciceri F; Bacigalupo A; Dodero A; Lucesole M; Patriarca F; Rambaldi A; Scimè R; Locasciulli A; Bandini G; Gianni AM; Tarella C; Olivieri A
J Clin Oncol; 2005 Sep; 23(27):6690-8. PubMed ID: 16170177
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
